Docetaxel induces radiation recall myositis: A case report
- Authors:
- Ayşegül Üçüncü Kefeli
- Beyza Aksu
View Affiliations
Affiliations: Department of Radiation Oncology, Kocaeli University Hospital, 41000 Kocaeli, Turkey, Vocational School of Health Services, Kocaeli University Hospital, 41000 Kocaeli, Turkey
- Published online on: June 15, 2022 https://doi.org/10.3892/etm.2022.11443
-
Article Number:
516
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The present study described a radiation recall (RR) myositis case following docetaxel chemotherapy in a 26‑year‑old female with metastatic breast cancer. The left pubis and left femur head and neck were treated with palliative radiotherapy to a dose of 20 Gy in 5 daily fractions. After 2 months, a whole‑body positron emission tomography scan revealed new lesions, and systemic treatment was initiated with docetaxel chemotherapy (75 mg/m2, every 3 weeks). After the second dose, the patient started to feel pain in her left femur with erythema on her skin on the lumbar and gluteal region, in addition to swelling. On magnetic resonance imaging, edematous changes, increased signal enhancement on T2 and increased contrast uptake of muscles were observed, suggesting myositis on the irradiated field. The present study is the second case report published on the literature on RR myositis following docetaxel treatment, which emphasizes the importance of awareness about this phenomenon when considering differential diagnosis of pain.
View References
1
|
Friedlander PA, Bansal R, Schwartz L,
Wagman R, Posner J and Kemeny N: Gemcitabine-related radiation
recall preferentially involves internal tissue and organs. Cancer.
100:1793–1799. 2004.PubMed/NCBI View Article : Google Scholar
|
2
|
D'Angio GJ, Farber S and Maddock CL:
Potentiation of X-ray effects by actinomycin D. Radiology.
73:175–177. 1959.PubMed/NCBI View
Article : Google Scholar
|
3
|
Azria D, Magné N, Zouhair A, Castadot P,
Culine S, Ychou M, Stupp R, Van Houtte P, Dubois JB and Ozsahin M:
Radiation recall: A well-recognized but neglected phenomenon.
Cancer Treat Rev. 31:555–570. 2005.PubMed/NCBI View Article : Google Scholar
|
4
|
Chao HH, Feld EK, Narayan V, Sebro R and
Jones JA: Radiation recall myositis after carboplatin/docetaxel
chemotherapy. Pract Radiat Oncol. 10:e50–e52. 2020.PubMed/NCBI View Article : Google Scholar
|
5
|
Ho MY and Mackey JR: Presentation and
management of docetaxel-related adverse effects in patients with
breast cancer. Cancer Manag Res 27:. 6:253–259. 2014.PubMed/NCBI View Article : Google Scholar
|
6
|
Seguin C, Kovacevich N and Voutsadakis IA:
Docetaxel-associated myalgia-arthralgia syndrome in patients with
breast cancer. Breast Cancer (Dove Med Press). 9:39–44.
2017.PubMed/NCBI View Article : Google Scholar
|
7
|
Perel-Winkler A, Belokovskaya R, Amigues
I, Larusso M and Hussain N: A case of docetaxel induced myositis
and review of the literature. Case Rep Rheumatol.
2015(795242)2015.PubMed/NCBI View Article : Google Scholar
|
8
|
Zulian GB and Aapro MS: Docetaxel and
radiation-recall severe mucositis. Ann Oncol. 5(964)1994.PubMed/NCBI View Article : Google Scholar
|
9
|
Mizumoto M, Harada H and Asakura H:
Frequency and characteristics of docetaxel-induced radiation recall
phenomenon. Int J Radiat Oncol Biol Phys. 66:1187–1191.
2006.PubMed/NCBI View Article : Google Scholar
|
10
|
O'Regan KN, Nishino M, Armand P, Kelly PJ,
Hwang DG and Di*Salvo D: Sonographic features of pectoralis muscle
necrosis secondary to gemcitabine-induced radiation recall: Case
report and review of current literature. J Ultrasound Med.
29:1499–1502. 2010.PubMed/NCBI View Article : Google Scholar
|
11
|
Ravishankar A, Park SS, Olivier KR and
Corbin KS: Gemcitabine-induced radiation recall myositis: Case
report and review of the literature. Case Rep Oncol. 11:168–178.
2018.PubMed/NCBI View Article : Google Scholar
|
12
|
Naranjo CA, Busto U, Sellers EM, Sandor P,
Ruiz I, Roberts EA, Janecek E, Domecq C and Greenblatt DJ: A method
for estimating the probability of adverse drug reactions. Clin
Pharmacol Ther. 30:239–245. 1981.PubMed/NCBI View Article : Google Scholar
|
13
|
Camidge R and Price A: Characterizing the
phenomenon of radiation recall dermatitis. Radiother Oncol.
59:237–245. 2001.PubMed/NCBI View Article : Google Scholar
|